| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 5,979,077 | 1,696,899 |
| Effect of exchange rate changes on cash | 8,568 | 7,338 |
| Change in cash and cash equivalents | 2,456,426 | 307,577 |
| Cash and cash equivalents at beginning of period | 1,659,353 | - |
| Cash and cash equivalents at end of period | 4,115,779 | - |
60 DEGREES PHARMACEUTICALS, INC. (SXTP)
60 DEGREES PHARMACEUTICALS, INC. (SXTP)